stockrowTeleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.
- Revenue
- +28.9%
- EPS
- −17.3%
- Free cash flow
- +220.1%
- Total debt
- +47.7%
Quarter to June 2026, against a year earlier
Follow TFX
Alert me
Teleflex Incorporated (TFX) Return on assets
Teleflex Incorporated's return on assets over the twelve months to 30 June 2026 was −14.6%, down 1.7 percentage points from fiscal 2025 (−12.9%). Over the past ten years it has ranged from −12.9% (fiscal 2025) to 7.33% (fiscal 2019) — the current reading is the lowest in ten years. That is below the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | −12.9% | (13.85) |
| FY2024 | 0.95% | (3.98) |
| FY2023 | 4.93% | (0.33) |
| FY2022 | 5.26% | (1.66) |
| FY2021 | 6.92% | 1.94 |
| FY2020 | 4.98% | (2.35) |
| FY2019 | 7.33% | 4.11 |
| FY2018 | 3.22% | 0.19 |
| FY2017 | 3.03% | (3.09) |
| FY2016 | 6.12% | (0.16) |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| NVST Envista Holdings Corporation compare | 11.3% |
| MMSI Merit Medical Systems, Inc. compare | 5.76% |
| ATR AptarGroup, Inc. compare | 5.23% |
| AVTR Avantor, Inc. compare | 2.89% |
| ICUI ICU Medical, Inc. compare | 1.50% |
| BLCO Bausch + Lomb Corporation compare | −0.80% |
| MMED MiniMed Group, Inc. compare | −6.27% |
| TFX Teleflex Incorporated | −14.6% |
| PLSE Pulse Biosciences, Inc compare | −54.0% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on TFX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement